Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia

Abstract

Refractory anemia with excess blasts in transformation (RAEB-T) is a subgroup of myelodysplastic syndrome (MDS) in which the bone marrow blast count ranges from 20% to 30%. The recently proposed World Health Organization Classification of Hematologic Malignancies eliminated this category from MDS by lowering the blast count cutoff for acute myeloid leukemia (AML) from 30% to 20%. However, MDS is distinguished from AML by a significant increase in apoptosis. To investigate the difference in apoptosis between RAEB-T, AML, and other categories of MDS, we prospectively analyzed fresh bone marrow samples using the Annexin V and mitochondrial potential assays. There was a significantly higher level of apoptosis in RAEB-T than in AML according to both assays, while no significant differences between RAEB-T and other categories of MDS were noted. The data suggest that RAEB-T is more likely to be an advanced stage of MDS and biologically different from AML.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Sultan C . The French–American–British (FAB) Co-operative Group. Proposals for the classification of the myelodysplastic syndromes Br J Haematol 1982 51: 189–199

    Article  CAS  Google Scholar 

  2. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD . World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissue. Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 J Clin Oncol 1999 17: 3835–3849

    Article  CAS  Google Scholar 

  3. Yoshida Y . Hypothesis: apoptosis may be the mechanism responsible for the premature intramedullary cell death in the myelodysplastic syndrome Leukemia 1993 7: 144–146

    CAS  PubMed  Google Scholar 

  4. Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A . Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes Blood 1995 86: 268–276

    CAS  Google Scholar 

  5. Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A . Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis Am J Hematol 1995 48: 143–154

    Article  CAS  Google Scholar 

  6. Rajapaksa R, Ginzton JP, Rott LS, Greenberg PL . Altered oncoprotein expression and apoptosis in myelodysplastic syndromemarrow cells Blood 1996 88: 4275–4287

    CAS  Google Scholar 

  7. Merchant SH, Gonchoroff NJ, Hutchison RE . Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes Cytometry 2001 46: 28–32

    Article  CAS  Google Scholar 

  8. Irvine AE, Magill MK, Somerville LE, McMullin MF . Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia Exp Hematol 1998 26: 435–439

    CAS  PubMed  Google Scholar 

  9. Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A . The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS Blood 2000 96: 3932–3938

    CAS  PubMed  Google Scholar 

  10. Albitar M, Beran M, O'Brien S, Kantarjian H, Freireich E, Keating M, Estey E . Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemia Blood 2000 96: 372–373

    CAS  PubMed  Google Scholar 

  11. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C . A novel assay for apoptosis. Flow cytometric detection of phosphatidyl serine expression on early apoptotic cells using fluorescein labeled Annexin V J Immunol Meth 1995 164: 39–51

    Article  Google Scholar 

  12. Green DR, Reed JC . Mitochondria and apoptosis Science 1998 281: 1309–1312

    Article  CAS  Google Scholar 

  13. Suzuki K, Kostin S, Person V, Elsasser A, Schaper J . Time course of the apoptotic cascade and effects of caspase inhibitors in adult rat ventricular cardiomyocytes J Mol Cell Cardiol 2001 33: 983–994

    Article  CAS  Google Scholar 

  14. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C . A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic action 5, 5’, 6, 6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolcarbocyanine iodide Biochem Biophy Res Commun 1993 197: 40–45

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huh, Y., Jilani, I., Estey, E. et al. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia. Leukemia 16, 2249–2252 (2002). https://doi.org/10.1038/sj.leu.2402704

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402704

Keywords

This article is cited by

Search

Quick links